Ana Cristina Bairrada Fortuna

Algoritmi | User | Ana Cristina Bairrada Fortuna

At LASI

Member of the CIBIT R&D Unit

Academic Degree

Current Position

Personal Webpage

Personal Email

anacfortuna@gmail.com

Orcid

0000-0001-6981-6639

Researcher ID

FCT Public Key

Ciência ID

E510-8BF0-1756

Google Scholar

About Me

Ana Fortuna is graduated in Pharmaceutical Sciences since 2007 and obtained the PhD degree in Pharmaceutical Sciences, specialty of Pharmacology, in 2011 at the Faculty of Pharmacy of University of Coimbra (FFUC). In 2022, Ana Fortuna acquired the European Certified Pharmacologist (EuCP) from the Federation of European Pharmacological Societies (EPHAR) e European Association for Clinical Pharmacology and Therapeutics (EACPT). She is an Assistant Professor at FFUC since 2011 in the area of Pharmacology and Pharmaceutical Care and an integrated researcher at the Coimbra Institute for Biomedical Imaging and Translational Research of University of Coimbra (CIBIT). Ana Fortuna is member of the INTERNATIONAL NASAL RESEARCH GROUP as well as of the Associated Laboratory for Intelligent Systems and the Collaborative Laboratory for Promoting Translation and Discovery of Medicines (Bioscale). Ana Fortuna is currently the supervisor of 5 PhD students (1 in collaboration with the pharmaceutical industry, 2 with University of Barcelona), co-supervisor of 2 PhD students and supervisor of 4 Master students in Applied Pharmacology. She has already successfully supervised 4 PhD students, 25 master's students and 36 integrated master's degree students. Ana Fortuna is the Coordinator of the Applied Pharmacology Master since 2018, a member of the Pedagogical Council of FFUC since 2016, of the Equivalence Committee since 2019, of the Scientific Council of Institute for Nuclear Sciences Applied to Health (ICNAS) and of the Scientific Committee for coordinating the Doctorate in Nursing study cycle. Participated in 102 evaluation juries, namely 14 PhD juries (3 as main arguer), 56 Master's juries (35 as main arguer), 1 Undergraduate, 20 Doctoral Program Seminars and 9 public competition juries for hiring PhD Researchers and Research Fellows, wherein Ana Fortuna was the President of the Jury. With a SCOPUS H-INDEX of 31 and 3014 total CITATIONS (Google Scholar: H-index 34 and 4218 citations), Ana Fortuna published 105 articles in international journals (96 in the 1st or 2nd quartile); among them, she was the first/last author or the corresponding author of 47 manuscripts. She is also the author of 3 INTERATIONAL PATENTS, 1 Editorial, 14 book chapters, and 131 oral/poster communications at scientific national/international meetings. Ana Fortuna was the principal investigator of the projects CENTRO-01-0145-FEDER-030752 (funded by FCT, 2018-2022) and SustaINsafety (funded by INOVC+, 2022-2023), both with the objective of developing and validating intranasal administration systems for delivery of drugs for the brain. She additionally integrates 1 European Project and 3 national projects. She has also integrated other 7 national projects, and coordinated/integrated 7 projects financed by the pharmaceutical industry, and 3 strategic institutional projects as an Integrated Member of CIBIT. Throughout academic and scientific career, Ana Fortuna was awarded 14 SCIENTIFIC AWARDS, integrating, in 2022 and 2023, the World's Top 2% Scientist, according to a study by Stanford University (USA) and the Elsevier publishing group. Ana Fortuna has been invited to participate in relevant activities, involving the public and private sectors, highlighting the provision of services to public and private entities in conjunction with the University of Coimbra through the COORDINATION OF THE TECHNOLOGICAL PLATFORM OF THE UNIVERSITY OF COIMBRA – Unit of Pharmacokinetics and Bioanalysis. Ana Fortuna also leads the PkXplorer project, integrated at the University of Coimbra and in the Virtual Incubator at Instituto Pedro Nunes (IPN). The main research areas of investigation include: interaction between drugs and efflux transporters, in vitro/in vivo pharmacokinetics and pharmacodynamics of new drugs for depression, epilepsy and Alzheimer´s disease, as well as development/validation of bioanalytical techniques that are employed on drug pharmacokinetics monitoring throughout a personalized pharmacotherapy. These researches allowed Ana Fortuna to establish different collaborations, namely with pharmaceutical industries (BIAL Laboratories, Hovione, Aptar Pharma), Centro Hospitalar e Universitário de Coimbra (CHUC, EPE, Coimbra, Portugal) and other public national (University of Beira Interior, University of Porto, University of Aveiro and University of Algarve). At the international level, she collaborates with recognized researchers from Spain (University of Barcelona and University of Salamanca), Italy (University of Parma), Germany (Biberach University of Applied Sciences) and Brazil (Federal University of São Paulo).

Publications (258)

Chronopharmacokinetics of the antidepressant paroxetine: An in vitro and in vivo approach

Neuropharmacology

2025 | journal-article

Algoritmi | User | Ana Cristina Bairrada Fortuna

Custom menu section

Popular posts